Ovarian Cancer Deaths Can Be Reduced

A teal ribbon, which is an awareness ribbon fo...
Image via Wikipedia

Ovarian cancer is one of the many forms of malignant cancers that affect millions of women each year. When a woman is diagnosed with ovarian cancer, oncologists typically find tumors or cysts inside or on the ovary. These cysts may contain liquids or may be solid and retain the potential of traveling all over the body spreading the malignant cancer. However, with research and studies, oncologists have now devised treatments that could not only save patients but also reduce deaths related to ovarian cancer by approximately 50%.

Since ovarian cancer is dismally hard to detect, many patients spend years without treating it. Eventually, when significant symptoms like abdominal pain, pelvic pain, indigestion, gas, constipation and unusual vaginal bleeding occur, oncologists run tests and administer medicines to combat the cancer. While traditional treatment options are always available to women, oncologists in Canada have revealed that removing fallopian tubes while performing hysterectomies can increase chances of survival after diagnosis of the cancer.

While performing hysterectomies, gynecologists often cut a part of the fallopian tube and tie it at the end to prevent the sperms from entering them during intercourse. But if the new technique is to be followed, a gynaecologic oncologist will simply remove the entire fallopian tube from the body.
A study of ovarian cancer has revealed that ovarian tumors usually take birth in the fallopian tubes and not the ovary themselves, as is popularly the notion now. Hence, when the new treatment of discarding the tube is implemented, the chances of cancer in the ovaries will drop down to 30% in the near future and to over 50% within the next twenty years.

While studies are still underway to better understand and treat various cancers, new developments usually instill hope in patients across the world. However, it is to be noted that new treatments often take years before they are accepted and approved by relevant medical bodies and are commercially usable for the general public.